NHI updates insider report for option grant

NATIONAL HEALTH INVESTORS INC updated an insider ownership report for SVP, Legal Affairs Elizabeth Jackson Blankenship to reflect a previously omitted stock option grant.

Accepted by SEC EDGAR 03/30/2026 - 06:30 PM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

3/A

Rhea-AI Filing Summary

NATIONAL HEALTH INVESTORS INC updated an insider ownership report for SVP, Legal Affairs Elizabeth Jackson Blankenship to reflect a previously omitted stock option grant. The amendment shows three tranches of stock options, each with an exercise price of $73.34 per share and expiring on March 3, 2030.

The options relate to underlying Common Stock in amounts of 8,333, 8,333 and 8,334 shares, with exercisability dates on March 3, 2025, March 3, 2026 and March 3, 2027, respectively. The footnote explains the grant was inadvertently omitted from the original Form 3 and is held directly.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Blankenship Elizabeth Jackson

Role SVP, Legal Affairs

Type	Security	Shares	Price	Value
Holding	Stock Option (Right to Buy) 2025	--	--	--
Holding	Stock Option (Right to Buy) 2025	--	--	--
Holding	Stock Option (Right to Buy) 2025	--	--	--

Holdings: Stock Option (Right to Buy) 2025 — 25,000 contracts (Direct)

Footnotes (1)

F1. Reflects a stock option grant that was inadvertently omitted from the original Form 3.

Key Figures

Exercise price: $73.34 per share Underlying shares tranche 1: 8,333 shares Underlying shares tranche 2: 8,333 shares +5 more

8 metrics

Exercise price $73.34 per share Stock Option (Right to Buy) 2025

Underlying shares tranche 1 8,333 shares Common Stock underlying first option tranche

Underlying shares tranche 2 8,333 shares Common Stock underlying second option tranche

Underlying shares tranche 3 8,334 shares Common Stock underlying third option tranche

Option expiration date March 3, 2030 All reported stock option tranches

First exercisability date March 3, 2025 Stock Option (Right to Buy) 2025

Second exercisability date March 3, 2026 Stock Option (Right to Buy) 2025

Third exercisability date March 3, 2027 Stock Option (Right to Buy) 2025

Key Terms

Form 3/A, stock option grant, Stock Option (Right to Buy) 2025, underlying security, +1 more

5 terms

Form 3/A regulatory

"omitted from the original Form 3."

An amended Form 3 (Form 3/A) is a corrected or updated disclosure filed with regulators that revises an insider’s initial report of their ownership in a public company — typically for officers, directors or large shareholders. Investors use it like a corrected inventory list: it clarifies who owns how many shares and whether earlier reports had errors, helping assess insider confidence, possible conflicts and the accuracy of ownership records that can affect stock valuation and trust.

stock option grant financial

"Reflects a stock option grant that was inadvertently omitted"

Stock Option (Right to Buy) 2025 financial

"security_title": "Stock Option (Right to Buy) 2025""

underlying security financial

"underlying_security_title": "Common Stock""

exercise price financial

"conversion_or_exercise_price": "73.3400""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the amended Form 3/A for NHI disclose about Elizabeth Jackson Blankenship?

The amended Form 3/A updates Elizabeth Jackson Blankenship’s insider holdings to include a previously omitted stock option grant. It clarifies her direct right to acquire NHI Common Stock through options that were granted earlier but not shown on the original Form 3.

How many NHI shares are covered by the corrected stock option grant?

The corrected disclosure shows three stock option tranches over NHI Common Stock: 8,333 underlying shares, another 8,333 underlying shares, and 8,334 underlying shares. Each tranche represents a right to buy that number of shares if the options are exercised at the stated price.

What is the exercise price and expiration date of the NHI stock options in this Form 3/A?

Each reported stock option has an exercise price of $73.34 per share and an expiration date of March 3, 2030. This means the insider may choose to buy NHI Common Stock at $73.34 per share any time before that expiration, subject to exercisability dates.

When do the NHI stock options reported for Elizabeth Jackson Blankenship become exercisable?

The amendment shows three exercisability dates: March 3, 2025, March 3, 2026 and March 3, 2027. Each date corresponds to a separate tranche of stock options, allowing staged potential exercises over three years before final expiration in 2030.

Does the NHI Form 3/A indicate a new transaction or simply correct prior reporting?

The Form 3/A indicates a correction to prior reporting, not a new option transaction. A footnote explains the stock option grant was previously made but inadvertently omitted from the original Form 3, so this amendment brings the insider ownership record up to date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Blankenship Elizabeth Jackson

(Last)

(First)

(Middle)

222 ROBERT ROSE DR

(Street)

MURFREESBORO

TENNESSEE

37129

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/17/2026

3. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
03/04/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Legal Affairs

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy) 2025	03/03/2025	03/03/2030	Common Stock	8,333⁽¹⁾	$73.34	D
Stock Option (Right to Buy) 2025	03/03/2026	03/03/2030	Common Stock	8,333⁽¹⁾	$73.34	D
Stock Option (Right to Buy) 2025	03/03/2027	03/03/2030	Common Stock	8,334⁽¹⁾	$73.34	D

Explanation of Responses:

1. Reflects a stock option grant that was inadvertently omitted from the original Form 3.

	/s/ Kimberly V. Ouimet, by limited power of attorney	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR